Last reviewed · How we verify
A Randomized, Double-blind, Placebo-controlled Study Comparing the Healthy Levels of Blood Sugar and Endothelial Function of PEAK ATP® With GlycoCarn®, PEAK ATP® and GlycoCarn® Supplementation Versus Placebo
To purpose of this study is to assess the effectiveness, safety and tolerability of PEAK ATP® with GlycoCarn®, PEAK ATP® and GlycoCarn® on levels of blood sugar and endothelial function improvement which may lead to improved vascular health.
Details
| Lead sponsor | Supplement Formulators, Inc. |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 60 |
| Start date | 2012-07 |
| Completion | 2016-04 |
Conditions
- Blood Sugar
- Endothelial Function
Interventions
- PEAK ATP® with GlycoCarn®
- PEAK ATP®
- GlycoCarn®
- Placebo
Primary outcomes
- Mean change in plasma glucose — 90 days
Countries
United States